An cost function for estimating annual costs of formal care for Alzheimer's disease dementia: development using Swedish registers
Yohannes Mengistu Balcha1; Linus Jönsson1; Maria Eriksdotter2,3; Nils Skajaa4; Niels Juul Brogaard4; Jens Gundgaard4; Pepa Polavieja4; Alice Clark4; Henrik Zetterberg5,6,7,8,9,10,11,12; Silke Kern13,14,15; Tobias Borgh Skillbäck13,15; Xin Xia1
MATERIALS AVAILABLE
Poster
Thursday, 19 March 2026
11:10 - 12:50
CET
Add to calendar
ORAL PRESENTATION
Insights into the evoke and evoke+ trials of semaglutide in early Alzheimer’s disease: A deep dive with additional data and analyses
Jeffrey L. Cummings1, Alireza Atri2–4, Mary Sano5,6, Henrik Zetterberg7, Philip Scheltens8,9, Filip K. Knop10, Peter Johannsen10, Christian A Wichmann10, Rikke M. Abschneider10, Anna Areovimata10, Marie R. Sass10; Joseph Polex-Wolf10, Dylan Belmont-Rausch10, Martí Jiménez-Mausbach10, Howard H. Feldman11